Cargando…

Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long‐term, open‐label safety study

OBJECTIVE: Diazepam nasal spray (Valtoco), indicated for acute treatment of frequent seizure activity (seizure clusters) in patients with epilepsy ≥6 years of age, is designed to be a rapid, noninvasive, socially acceptable route of administration. This interim analysis evaluated the safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Segal, Eric B., Tarquinio, Daniel, Miller, Ian, Wheless, James W., Dlugos, Dennis, Biton, Victor, Cascino, Gregory D., Desai, Jay, Hogan, R. Edward, Liow, Kore, Sperling, Michael R., Vazquez, Blanca, Cook, David F., Rabinowicz, Adrian L., Carrazana, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252651/ https://www.ncbi.nlm.nih.gov/pubmed/33942315 http://dx.doi.org/10.1111/epi.16901

Ejemplares similares

Consistent safety and tolerability of Valtoco(®) (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
por: Miller, Ian, et al.
Publicado: (2021)

Final results from a Phase 3, long‐term, open‐label, repeat‐dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy
por: Wheless, James W., et al.
Publicado: (2021)

Use of second doses of Valtoco® (diazepam nasal spray) across 24 hours after the initial dose for out‐of‐hospital seizure clusters: Results from a phase 3, open‐label, repeat‐dose safety study
por: Sperling, Michael R., et al.
Publicado: (2022)

Safety of Diazepam Nasal Spray in Pediatric Patients With Developmental Epileptic Encephalopathies: Results From a Long-term Phase 3 Safety Study
por: Tarquinio, Daniel, et al.
Publicado: (2023)

Lack of clinically relevant differences in safety and pharmacokinetics after second‐dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis
por: Cascino, Gregory D., et al.
Publicado: (2022)

Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
por: Hogan, Robert Edward, et al.
Publicado: (2020)

Significant improvements in SEIzure interVAL (time between seizure clusters) across time in patients treated with diazepam nasal spray as intermittent rescue therapy for seizure clusters
por: Misra, Sunita N., et al.
Publicado: (2022)

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters
por: Cloyd, James, et al.
Publicado: (2021)

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers
por: Hogan, R. Edward, et al.
Publicado: (2020)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Racial/Ethnic Disparities in the Alzheimer’s Disease Link with Cardio and Cerebrovascular Diseases, Based on Hawaii Medicare Data
por: Siriwardhana, Chathura, et al.
Publicado: (2023)

Concomitant Opioid and Diazepam Use in Plastic Surgery
por: Shaum, Katherine M., et al.
Publicado: (2019)

Future opportunities for research in rescue treatments
por: Wheless, James W., et al.
Publicado: (2022)

Effect of Diazepam on Severity of Acute Pancreatitis: Possible Involvement of Peripheral Benzodiazepine Receptors
por: Abed, Alireza, et al.
Publicado: (2013)

Treatment of Seizure Clusters in Epilepsy: A Narrative Review on Rescue Therapies
por: Becker, Danielle A., et al.
Publicado: (2023)

Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
por: Ruchi, Rupam, et al.
Publicado: (2019)

Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018
por: Borrelli, Eric P, et al.
Publicado: (2022)

Mechanisms and Severity of Exercise Intolerance Following COVID-19 and Similar Viral Infections: A Comparative Review
por: Weldon, Edward J, et al.
Publicado: (2023)

Identification of associations and distinguishing moyamoya disease from ischemic strokes of other etiologies: A retrospective case-control study
por: Sutton, Cori Xiu Yue, et al.
Publicado: (2022)

VALTOCO(®) (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
por: Cornett, Elyse M., et al.
Publicado: (2021)

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication
por: Andrashko, Veronika, et al.
Publicado: (2020)

Abnormal Temporal Slowing on EEG Findings in Preclinical Alzheimer’s Disease Patients With the ApoE4 Allele: A Pilot Study
por: Kim, Nathan N, et al.
Publicado: (2023)

Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication
por: Liow, Kore
Publicado: (2009)

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

Improvement of Intranasal Drug Delivery with Intravail(®) Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System
por: Rabinowicz, Adrian L., et al.
Publicado: (2021)

Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers
por: Madden, Stuart, et al.
Publicado: (2023)

Reproductive toxicology. Diazepam.
Publicado: (1997)

Demographic recruitment bias of adults in United States randomized clinical trials by disease categories between 2008 to 2019: a systematic review and meta-analysis
por: Buffenstein, Ilana, et al.
Publicado: (2023)

Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials
por: Diekamp, Bettina, et al.
Publicado: (2021)

COVID-19 Is Changing Our Understanding of the Neuroscience of Viral Infections: What We Can Do to Prepare for the Future?
por: Liow, Kore Kai, et al.
Publicado: (2022)

Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
por: Mir, Soodaba, et al.
Publicado: (2020)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

A randomized, open‐label, two‐treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults
por: Rogawski, Michael A., et al.
Publicado: (2022)

Implications of Seizure-Cluster Treatment on Healthcare Utilization: Use of Approved Rescue Medications
por: Rabinowicz, Adrian L, et al.
Publicado: (2022)

Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
por: Wheless, James, et al.
Publicado: (2020)

Diazepam Premedication in Primary Augmentation Mammoplasty
por: Lucich, Elizabeth A., et al.
Publicado: (2020)

Porcine diazepam-binding inhibitor and bovine diazepam-binding inhibitor affect morphine antinociception via different receptors
por: Chen, Yu-Zhen, et al.
Publicado: (2016)

Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: Behavioral studies with concomitant in vivo CA(1) hippocampal norepinephrine and serotonin release detection in the behaving animal
por: Broderick, Patricia A., et al.
Publicado: (1998)

Subgroup growth
por: Lubotzky, Alexander, et al.
Publicado: (2003)

Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro.
por: Kalashnikov, Sergey V, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_uuroj8h8g01ev94aqlaolor40e